Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.
Identifieur interne : 000021 ( Hal/Checkpoint ); précédent : 000020; suivant : 000022Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.
Auteurs : Anna Migdalska-Richards [Royaume-Uni] ; Liam Daly [Royaume-Uni] ; Erwan Bezard [France] ; Anthony H V. Schapira [Royaume-Uni]Source :
- Annals of Neurology [ 0364-5134 ] ; 2016-11.
Abstract
Gaucher disease is caused by mutations in the glucocerebrosidase 1 gene that result in deficiency of the lysosomal enzyme glucocerebrosidase. Both homozygous and heterozygous glucocerebrosidase 1 mutations confer an increased risk for developing Parkinson disease. Current estimates indicate that 10 to 25% of Parkinson patients carry glucocerebrosidase 1 mutations. Ambroxol is a small molecule chaperone that has been shown to increase glucocerebrosidase activity in vitro. This study investigated the effect of ambroxol treatment on glucocerebrosidase activity and on α-synuclein and phosphorylated α-synuclein protein levels in mice.
Url:
DOI: 10.1002/ana.24790.
Links toward previous steps (curation, corpus...)
Links to Exploration step
Hal:hal-01456949Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.</title>
<author><name sortKey="Migdalska Richards, Anna" sort="Migdalska Richards, Anna" uniqKey="Migdalska Richards A" first="Anna" last="Migdalska-Richards">Anna Migdalska-Richards</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-95915" status="INCOMING"> <orgName>Department of Clinical Neurosciences</orgName>
<desc> <address> <country key="GB"></country>
</address>
</desc>
<listRelation> <relation active="#struct-300875" type="direct"></relation>
<relation active="#struct-310129" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-300875" type="direct"><org type="institution" xml:id="struct-300875" status="VALID"> <orgName>University College of London [London]</orgName>
<desc> <address> <addrLine>Gower Street, London WC1E 6BT </addrLine>
<country key="GB"></country>
</address>
<ref type="url">http://www.ucl.ac.uk/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-310129" type="direct"><org type="institution" xml:id="struct-310129" status="INCOMING"> <orgName>Institute of Neurology</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Daly, Liam" sort="Daly, Liam" uniqKey="Daly L" first="Liam" last="Daly">Liam Daly</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-95915" status="INCOMING"> <orgName>Department of Clinical Neurosciences</orgName>
<desc> <address> <country key="GB"></country>
</address>
</desc>
<listRelation> <relation active="#struct-300875" type="direct"></relation>
<relation active="#struct-310129" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-300875" type="direct"><org type="institution" xml:id="struct-300875" status="VALID"> <orgName>University College of London [London]</orgName>
<desc> <address> <addrLine>Gower Street, London WC1E 6BT </addrLine>
<country key="GB"></country>
</address>
<ref type="url">http://www.ucl.ac.uk/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-310129" type="direct"><org type="institution" xml:id="struct-310129" status="INCOMING"> <orgName>Institute of Neurology</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Bezard, Erwan" sort="Bezard, Erwan" uniqKey="Bezard E" first="Erwan" last="Bezard">Erwan Bezard</name>
<affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-467086" status="INCOMING"> <orgName>Univ de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France.</orgName>
<desc> <address> <addrLine>146 rue Léo Saignat - CS 6129233076 Bordeaux cedex</addrLine>
<country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Schapira, Anthony H V" sort="Schapira, Anthony H V" uniqKey="Schapira A" first="Anthony H V" last="Schapira">Anthony H V. Schapira</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-95915" status="INCOMING"> <orgName>Department of Clinical Neurosciences</orgName>
<desc> <address> <country key="GB"></country>
</address>
</desc>
<listRelation> <relation active="#struct-300875" type="direct"></relation>
<relation active="#struct-310129" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-300875" type="direct"><org type="institution" xml:id="struct-300875" status="VALID"> <orgName>University College of London [London]</orgName>
<desc> <address> <addrLine>Gower Street, London WC1E 6BT </addrLine>
<country key="GB"></country>
</address>
<ref type="url">http://www.ucl.ac.uk/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-310129" type="direct"><org type="institution" xml:id="struct-310129" status="INCOMING"> <orgName>Institute of Neurology</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Royaume-Uni</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-01456949</idno>
<idno type="halId">hal-01456949</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-01456949</idno>
<idno type="url">https://hal.archives-ouvertes.fr/hal-01456949</idno>
<idno type="doi">10.1002/ana.24790.</idno>
<date when="2016-11">2016-11</date>
<idno type="wicri:Area/Hal/Corpus">000070</idno>
<idno type="wicri:Area/Hal/Curation">000070</idno>
<idno type="wicri:Area/Hal/Checkpoint">000021</idno>
<idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000021</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.</title>
<author><name sortKey="Migdalska Richards, Anna" sort="Migdalska Richards, Anna" uniqKey="Migdalska Richards A" first="Anna" last="Migdalska-Richards">Anna Migdalska-Richards</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-95915" status="INCOMING"> <orgName>Department of Clinical Neurosciences</orgName>
<desc> <address> <country key="GB"></country>
</address>
</desc>
<listRelation> <relation active="#struct-300875" type="direct"></relation>
<relation active="#struct-310129" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-300875" type="direct"><org type="institution" xml:id="struct-300875" status="VALID"> <orgName>University College of London [London]</orgName>
<desc> <address> <addrLine>Gower Street, London WC1E 6BT </addrLine>
<country key="GB"></country>
</address>
<ref type="url">http://www.ucl.ac.uk/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-310129" type="direct"><org type="institution" xml:id="struct-310129" status="INCOMING"> <orgName>Institute of Neurology</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Daly, Liam" sort="Daly, Liam" uniqKey="Daly L" first="Liam" last="Daly">Liam Daly</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-95915" status="INCOMING"> <orgName>Department of Clinical Neurosciences</orgName>
<desc> <address> <country key="GB"></country>
</address>
</desc>
<listRelation> <relation active="#struct-300875" type="direct"></relation>
<relation active="#struct-310129" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-300875" type="direct"><org type="institution" xml:id="struct-300875" status="VALID"> <orgName>University College of London [London]</orgName>
<desc> <address> <addrLine>Gower Street, London WC1E 6BT </addrLine>
<country key="GB"></country>
</address>
<ref type="url">http://www.ucl.ac.uk/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-310129" type="direct"><org type="institution" xml:id="struct-310129" status="INCOMING"> <orgName>Institute of Neurology</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Bezard, Erwan" sort="Bezard, Erwan" uniqKey="Bezard E" first="Erwan" last="Bezard">Erwan Bezard</name>
<affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-467086" status="INCOMING"> <orgName>Univ de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France.</orgName>
<desc> <address> <addrLine>146 rue Léo Saignat - CS 6129233076 Bordeaux cedex</addrLine>
<country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Schapira, Anthony H V" sort="Schapira, Anthony H V" uniqKey="Schapira A" first="Anthony H V" last="Schapira">Anthony H V. Schapira</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-95915" status="INCOMING"> <orgName>Department of Clinical Neurosciences</orgName>
<desc> <address> <country key="GB"></country>
</address>
</desc>
<listRelation> <relation active="#struct-300875" type="direct"></relation>
<relation active="#struct-310129" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-300875" type="direct"><org type="institution" xml:id="struct-300875" status="VALID"> <orgName>University College of London [London]</orgName>
<desc> <address> <addrLine>Gower Street, London WC1E 6BT </addrLine>
<country key="GB"></country>
</address>
<ref type="url">http://www.ucl.ac.uk/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-310129" type="direct"><org type="institution" xml:id="struct-310129" status="INCOMING"> <orgName>Institute of Neurology</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Royaume-Uni</country>
</affiliation>
</author>
</analytic>
<idno type="DOI">10.1002/ana.24790.</idno>
<series><title level="j">Annals of Neurology</title>
<idno type="ISSN">0364-5134</idno>
<imprint><date type="datePub">2016-11</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="0">Gaucher disease is caused by mutations in the glucocerebrosidase 1 gene that result in deficiency of the lysosomal enzyme glucocerebrosidase. Both homozygous and heterozygous glucocerebrosidase 1 mutations confer an increased risk for developing Parkinson disease. Current estimates indicate that 10 to 25% of Parkinson patients carry glucocerebrosidase 1 mutations. Ambroxol is a small molecule chaperone that has been shown to increase glucocerebrosidase activity in vitro. This study investigated the effect of ambroxol treatment on glucocerebrosidase activity and on α-synuclein and phosphorylated α-synuclein protein levels in mice.</div>
</front>
</TEI>
<hal api="V3"> <titleStmt> <title xml:lang="en">Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.</title>
<author role="aut"> <persName> <forename type="first">Anna</forename>
<surname>Migdalska-Richards</surname>
</persName>
<idno type="halauthorid">1478353</idno>
<affiliation ref="#struct-95915"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Liam</forename>
<surname>Daly</surname>
</persName>
<idno type="halauthorid">1478354</idno>
<affiliation ref="#struct-95915"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Erwan</forename>
<surname>Bezard</surname>
</persName>
<idno type="halauthorid">537314</idno>
<affiliation ref="#struct-467086"></affiliation>
<affiliation ref="#struct-467087"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Anthony H V</forename>
<surname>Schapira</surname>
</persName>
<idno type="halauthorid">766195</idno>
<affiliation ref="#struct-95915"></affiliation>
</author>
<editor role="depositor"> <persName> <forename>Chantal</forename>
<surname>GUERIN</surname>
</persName>
<email type="md5">eb4bde61f74652335183b0bd05630b2c</email>
<email type="domain">u-bordeaux.fr</email>
</editor>
</titleStmt>
<editionStmt> <edition n="v1" type="current"> <date type="whenSubmitted">2017-02-06 10:28:47</date>
<date type="whenModified">2017-02-07 01:00:13</date>
<date type="whenReleased">2017-02-06 10:28:47</date>
<date type="whenProduced">2016-11</date>
</edition>
<respStmt> <resp>contributor</resp>
<name key="321070"> <persName> <forename>Chantal</forename>
<surname>GUERIN</surname>
</persName>
<email type="md5">eb4bde61f74652335183b0bd05630b2c</email>
<email type="domain">u-bordeaux.fr</email>
</name>
</respStmt>
</editionStmt>
<publicationStmt> <distributor>CCSD</distributor>
<idno type="halId">hal-01456949</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-01456949</idno>
<idno type="halBibtex">migdalskarichards:hal-01456949</idno>
<idno type="halRefHtml">Annals of Neurology, Wiley, 2016, pp.766-775. <10.1002/ana.24790.></idno>
<idno type="halRef">Annals of Neurology, Wiley, 2016, pp.766-775. <10.1002/ana.24790.></idno>
</publicationStmt>
<seriesStmt> <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
</seriesStmt>
<notesStmt> <note type="audience" n="2">International</note>
<note type="popular" n="0">No</note>
<note type="peer" n="1">Yes</note>
</notesStmt>
<sourceDesc> <biblStruct> <analytic> <title xml:lang="en">Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.</title>
<author role="aut"> <persName> <forename type="first">Anna</forename>
<surname>Migdalska-Richards</surname>
</persName>
<idno type="halauthorid">1478353</idno>
<affiliation ref="#struct-95915"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Liam</forename>
<surname>Daly</surname>
</persName>
<idno type="halauthorid">1478354</idno>
<affiliation ref="#struct-95915"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Erwan</forename>
<surname>Bezard</surname>
</persName>
<idno type="halauthorid">537314</idno>
<affiliation ref="#struct-467086"></affiliation>
<affiliation ref="#struct-467087"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Anthony H V</forename>
<surname>Schapira</surname>
</persName>
<idno type="halauthorid">766195</idno>
<affiliation ref="#struct-95915"></affiliation>
</author>
</analytic>
<monogr> <idno type="halJournalId" status="VALID">10490</idno>
<idno type="issn">0364-5134</idno>
<idno type="eissn">1531-8249</idno>
<title level="j">Annals of Neurology</title>
<imprint> <publisher>Wiley</publisher>
<biblScope unit="pp">766-775</biblScope>
<date type="datePub">2016-11</date>
</imprint>
</monogr>
<idno type="doi">10.1002/ana.24790.</idno>
<idno type="pubmed">27859541</idno>
</biblStruct>
</sourceDesc>
<profileDesc> <langUsage> <language ident="en">English</language>
</langUsage>
<textClass> <classCode scheme="halDomain" n="sdv">Life Sciences [q-bio]</classCode>
<classCode scheme="halTypology" n="ART">Journal articles</classCode>
</textClass>
<abstract xml:lang="0">Gaucher disease is caused by mutations in the glucocerebrosidase 1 gene that result in deficiency of the lysosomal enzyme glucocerebrosidase. Both homozygous and heterozygous glucocerebrosidase 1 mutations confer an increased risk for developing Parkinson disease. Current estimates indicate that 10 to 25% of Parkinson patients carry glucocerebrosidase 1 mutations. Ambroxol is a small molecule chaperone that has been shown to increase glucocerebrosidase activity in vitro. This study investigated the effect of ambroxol treatment on glucocerebrosidase activity and on α-synuclein and phosphorylated α-synuclein protein levels in mice.</abstract>
<abstract xml:lang="1">Mice were treated with ambroxol for 12 days. After the treatment, glucocerebrosidase activity was measured in the mouse brain lysates. The brain lysates were also analyzed for α-synuclein and phosphorylated α-synuclein protein levels.</abstract>
<abstract xml:lang="2">Ambroxol treatment resulted in increased brain glucocerebrosidase activity in (1) wild-type mice, (2) transgenic mice expressing the heterozygous L444P mutation in the murine glucocerebrosidase 1 gene, and (3) transgenic mice overexpressing human α-synuclein. Furthermore, in the mice overexpressing human α-synuclein, ambroxol treatment decreased both α-synuclein and phosphorylated α-synuclein protein levels.</abstract>
<abstract xml:lang="3">Our work supports the proposition that ambroxol should be further investigated as a potential novel disease-modifying therapy for treatment of Parkinson disease and neuronopathic Gaucher disease to increase glucocerebrosidase activity and decrease α-synuclein and phosphorylated α-synuclein protein levels. Ann Neurol 2016;80:766-775.</abstract>
</profileDesc>
</hal>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Hal/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000021 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Hal/Checkpoint/biblio.hfd -nk 000021 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Hal |étape= Checkpoint |type= RBID |clé= Hal:hal-01456949 |texte= Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice. }}
This area was generated with Dilib version V0.6.29. |